R. Vanholder

Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.

R. Vanholder, N. Lameire, H. Schepkens, 2001, American Journal of Medicine.